Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC).

Mohty, M

Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC). [electronic resource] - Bone marrow transplantation Jan 2005 - 165-9 p. digital

Publication Type: Journal Article; Multicenter Study

0268-3369

10.1038/sj.bmt.1704756 doi


Adult
Female
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation--methods
Humans
Male
Middle Aged
Multiple Myeloma--mortality
Remission Induction
Retrospective Studies
Salvage Therapy--methods
Survival Analysis
Thalidomide--administration & dosage
Transplantation, Homologous
Treatment Outcome